{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T05:53:11Z","timestamp":1791179591082,"version":"4.1.0"},"reference-count":5,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:p>In this study, we identify the minimal important difference for two patient-reported quality of life instruments and provide evidence for their validity in pyoderma gangrenosum (PG). Such patient-reported outcome measures are being considered as co-primary endpoints in PG clinical trials by the US Food and Drug Administration.<\/jats:p>","DOI":"10.1093\/bjd\/ljaf381","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T12:05:39Z","timestamp":1758801939000},"page":"158-159","source":"Crossref","is-referenced-by-count":1,"title":["The clinical significance of quality of life in pyoderma gangrenosum"],"prefix":"10.1093","volume":"194","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-0197-7271","authenticated-orcid":false,"given":"Sophia","family":"Bostwick","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Oregon Health & Science University, Hillsboro Medical Center , Hillsboro, OR ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3162-4732","authenticated-orcid":false,"given":"Katherine","family":"Erickson","sequence":"additional","affiliation":[{"name":"Division of Dermatology, New York Medical College, Feinberg School of Medicine , Valhalla, NY ,","place":["USA"]},{"name":"Department of Dermatology, Oregon Health & Science University , Portland, OR ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5028-9269","authenticated-orcid":false,"given":"Alex G","family":"Ortega Loayza","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Oregon Health & Science University , Portland, OR ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"2026010607282315700_ljaf381-B1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000365390","article-title":"Determining the minimal clinically important difference and responsiveness of the Dermatology Life Quality Index (DLQI): further data","volume":"230","author":"Basra","year":"2015","journal-title":"Dermatology"},{"key":"2026010607282315700_ljaf381-B2","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaad.2019.09.008","article-title":"Achieving consensus on patient-reported outcome measures in clinical practice for inflammatory skin disorders","volume":"88","author":"Perez-Chada","year":"2023","journal-title":"J Am Acad Dermatol"},{"key":"2026010607282315700_ljaf381-B3","doi-asserted-by":"crossref","first-page":"4227","DOI":"10.1111\/iwj.14323","article-title":"Predilection sites of pyoderma gangrenosum: retrospective study of 170 diagnosed patients","volume":"20","author":"Moelleken","year":"2023","journal-title":"Int Wound J"},{"key":"2026010607282315700_ljaf381-B4","doi-asserted-by":"crossref","first-page":"m1714","DOI":"10.1136\/bmj.m1714","article-title":"Evaluating the credibility of anchor based estimates of minimal important differences for patient reported outcomes: instrument development and reliability study","volume":"369","author":"Devji","year":"2020","journal-title":"BMJ"},{"key":"2026010607282315700_ljaf381-B5","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1001\/jamadermatol.2023.3115","article-title":"Pain as a patient-\u00adreported outcome measure in pyoderma gangrenosum","volume":"159","author":"Erickson","year":"2023","journal-title":"JAMA Dermatol"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/bjd\/advance-article-pdf\/doi\/10.1093\/bjd\/ljaf381\/64406006\/ljaf381.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/1\/158\/64406006\/ljaf381.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/bjd\/article-pdf\/194\/1\/158\/64406006\/ljaf381.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T12:28:31Z","timestamp":1767702511000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/194\/1\/158\/8265394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":5,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,9,26]]},"published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/bjd\/ljaf381","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2025,9,26]]}}}